(Q53946789)

English

Effect of hepatic impairment on the pharmacokinetics of zolmitriptan.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9725544

Effect of hepatic impairment on the pharmacokinetics of zolmitriptan. (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9725544

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Dixon R

1

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9725544

French S

2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9725544

Kemp J

3

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9725544

Sellers M

4

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9725544

Leclerc V

5

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9725544

Delvaux M

6

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9725544

Rautureau J

7

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9725544

publication date

1 August 1998

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9725544

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9725544

38

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9725544

8

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9725544

694-701

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9725544

311C90: increasing the options for therapy with effective acute antimigraine 5HT1B/1D receptor agonists

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04808.X

21 January 2018

The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90).

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04808.X

21 January 2018

The pharmacokinetics and effects on blood pressure of multiple doses of the novel anti-migraine drug zolmitriptan (311C90) in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04808.X

21 January 2018

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04808.X

21 January 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04808.X

21 January 2018

Identifiers

10.1002/J.1552-4604.1998.TB04808.X

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9725544

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9725544

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53946789&oldid=2143984485"